/
DGNOF
$0.17+$0.01 (+4.38%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.13 – $0.29
24% from low
Exchange
OTC Link
OS
Borrow rate
3.09%
Moderate
Price (6 mo)
Loading chart…
Change$-0.10
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $326.5K | $326.5K | $331.5K | $267.1K | $438.8K | $170.2K | $103.8K | $65.6K |
| Cost of revenue | $1.1M | $1.1M | $805.0K | $614.6K | $857.1K | $1.0M | $1.0M | $185.4K |
| Gross profit | −$759.4K | −$759.4K | −$473.5K | −$347.5K | −$418.3K | −$837.9K | −$943.6K | −$119.8K |
| Gross margin | -232.6% | -232.6% | -142.8% | -130.1% | -95.3% | -492.4% | -909.0% | -182.4% |
| R&D | $922.5K | $0 | $0 | $0 | $603.3K | $0 | $0 | $1.5M |
| Operating income | −$2.9M | −$2.9M | −$2.7M | −$2.0M | −$2.6M | −$2.6M | −$3.8M | −$4.3M |
| EBITDA | −$2.7M | −$2.9M | −$2.6M | −$2.4M | −$2.1M | −$2.4M | −$3.6M | −$4.1M |
| Net income | −$3.8M | −$3.8M | −$3.4M | −$2.1M | −$2.6M | −$3.1M | −$4.3M | −$4.6M |
| Net margin | -1175.9% | -1175.9% | -1020.4% | -768.1% | -594.4% | -1833.9% | -4129.6% | -6957.0% |
| EPS (diluted) | -0.20 | -0.09 | -0.05 | -0.03 | -0.04 | -0.04 | -0.05 | -0.04 |
Annual figures · source: Financial Modeling Prep
Peer comparison
DIAGNOS INC
DIAGNOS INC
Held by traders on TradeandTell
No one on the platform currently holds DGNOF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in DGNOF as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2019-04-24 | 1-for-10reverse |
| 2014-07-16 | 1.5-for-1 |
Recent trades on TradeandTell
No one on the platform has traded DGNOF yet.